Caribou Biosciences, Inc. (NASDAQ: CRBU) reported Q3 EPS of ($0.44), $0.04 better than the analyst estimate of ($0.48). Revenue for the quarter came in at $3.3 million versus the consensus estimate of $3.54 million.

For earnings history and earnings-related data on Caribou Biosciences, Inc. (CRBU) click here.